Chapter 9: Socioeconomic implications
This is a live interactive document that provides the first collaborative edition for the book chapter on "Socioeconomic implications" (Book Table of contents). To access the pdf version of the chapter, please click here. To access to the previous edition please click here.
Comments and contributions:
By clicking on the green bubble that appears on the top right corner, you will be able to make comments on the corresponding section. Those individuals who make comments will be invited to join the next edition of this chapter as named contributors (if their comments make substantive additions) or will be named in acknowledgments (if not).
Follow section comments here!!
For any comments, questions, suggestions or technical support, please do not hesitate to contact us at email@example.com.
Table of contents
- Vignette: How it could be
- Why is this topic important?
- What do we know?
- Dependence associated with chronic diseases
- Influence of lifestyles and disease risk factors on healthcare costs
- What do we need to know?
- Economic implications
- Social and political implications
- What strategies could fill the gaps?
- References (click here to access)
- Creative commons license
Use the "full screen" button to increase the size of the window and you can edit better.
In the upper left, choose the format of the text by selecting from the dropdown menu:
- Paragraph: for normal text
- Chapter of the first level, second or third: to highlight the titles of the sections and build the index. Those statements that highlight in this format will automatically appear in the document index (table of contents).
Use the options Ctrl V or CMD V to paste and CtrlC / CMD C to copy, Ctrl X / CMD X to cut (in some browsers buttons doesn´t work)
Once you finish editing do not forget to save your changes by clicking the bottom left button Save or Cancel if you don´t want to save the changes.
More information here
Vignette: How it could be
Laura felt very pleased during the ceremony in which she handed the reins of the Ministry of Health and Wellbeing to her successor. She could not believe that so much had changed in just under a decade in the job. As a seasoned politician, economist and general practitioner, she was particularly proud to report how the joint effort of tens of thousands of committed people from all over the country and the world, had resulted in the elimination of most of the problems associated with the management of polypathologies, which had remained intractable for generations. She could remember with great satisfaction the day when the daring and detailed plan that she and her team had prepared was met with unconditional support from the head of state, legislators, the media, corporations, academic organizations and community agencies. With their support, it was dream-like to witness how bold policies and swift reallocation of internal resources had led to the implementation of a comprehensive and generous system of incentives that aligned the interests of all groups of stakeholders with the health needs of people living with multiple chronic diseases. Exceeding all of her own expectations, she had seen how this collective effort resulted in a significant improvement in all health indicators at a progressively lower cost! It was particularly joyful to remember the extraordinary support given by other members of cabinet to tackling disparities in health determinants; the enthusiasm with which the public had promoted the implementation of evidence-based secondary, tertiary and quaternary preventive interventions; how all the media and academic institutions had made patient education and self-management programs available to all those who needed them; how frontline clinicians, managers and caregivers had proposed, developed and introduced new health services; how clinicians with such a diverse background had embraced that now made supportive and palliative care services available to anyone, anywhere. With over 99% of health care services provided to those with multiple chronic diseases in the community, her country had become a beacon for others to follow.
Laura was now ready to embark on the next phase of her career. She had accepted an offer from the World Health rganization to head a global task force supported by her existing network of collaborators, and leading political, academic, clinical, community and corporate organizations, to promote the transformation of the management of multiple chronic diseases in all inhabited continents of the globe.
• Care for people with chronic diseases currently consumes the largest share of the healthcare budget in most countries, regardless of their level of income, and its overall share is expected to rise significantly in the decades to come. Care for people with multiple chronic diseases accounts for the greatest consumption of resources.
• There is a dearth of data on the economic, social and political impacts of multiple chronic diseases.
• Close integration and coordination of social and health services appear to be essential for the successful management of multiple chronic diseases. However, most policy, economic and management models seem to be anchored in the past by excessive compartmentalization and a lack of dialogue across levels of care, sectors and geographic regions.
• Given the potential political, societal, and economic challenge presented by inappropriate handling of multiple chronic diseases and the failure of market forces to contain them, political intervention, ideally backed by a global network of influential political, academic, clinical, corporate and community organizations, is justified.
Why is this topic important?
It is now obvious that the demand for health services is outstripping available resources in every society in the world, threatening not only the sustainability of the health system, but that of the economy as a whole. The prolongation of life expectancy is one of the factors most closely associated with this challenge. In the United States, for instance, the cost of healthcare for people over the age of 85 is six times greater than in people aged 50 to 54 and twice as much as in the 75-79 age group (1). There are different theories about how the increase in life expectancy relates to the burden of disease and its associated cost. The expansion of morbidity theory holds that the number of years humans will live with disease will increase (2), while the compressiontheory (3) describes a scenario in which a gain in years of healthy life will of morbidity lead to a postponement in disease and cost to more advanced life stages (i.e. they are compressed into that age segment). These different views have important social, political and economic implications. If, as a society, we invest resources to prolong the life of patients, this will expand their morbidity, while if we target risk and lifestyle habits we will probably delay and contract morbidity (4).
Regardless of how societies decide to meet the challenges associated with chronic diseases, any political or economic measure would need to take into account the fact that most of the costs are not associated with clinical services but with productivity losses (5, 6), and that expenditure on long-term care will represent an increasing proportion of healthcare costs in every economy, even in the most optimistic forecast models of cost containment (7). This will likely be compounded as the number of chronic diseases in the same person increases (8).
Despite the seriousness of the situation, neither organizations nor governments are decisively adopting measures to fight the chronic disease epidemic. Some consumer organizations do focus on the medical treatment of specific diseases, sometimes acting as pressure groups to increase investment in treatment, neglecting health promotion and disease prevention. Global donors are spending most of their funds on countering infectious disease and improving maternal and child health: very few resources are dedicated to countering chronic disease, and even fewer to tackling the challenges associated with polypathology.
What do we know?
Patients with five or more chronic conditions account for two thirds of the Medicare spend in the US (Figure 1). It has not been possible to find similar data from other countries, but it seems likely that the picture would be similar in other developed countries. In other words, caring for patients with complex chronic disease is increasingly the main activity and the main cost for health services. As patients have more chronic conditions they are more likely to be admitted to hospital (Figure 2), often unnecessarily and incurring considerable cost. In the UK, a small number of patients, most of them frail elderly individuals with polypathology, accounts for a high proportion of unplanned hospital admissions (Figure 3). These admissions entail a considerable cost.
Figure 1. Percent of medicare spending per person by number of Chronic Conditions (Average annual expenditure)
Source: Medicare Stantard Analytic File. (9)
Figure 2. Unnecessary hospital admissions related to the number of conditions coexisting in a person
Source: Medicare Standard Analytic File (9)
Figure 3. A small percentage of patients account for many hospital bed days
Source: Analysis of British Household Panel Survey (2001). (10)
Few studies are available on the cost of chronic illnesses for developing countries, and to our knowledge none evaluating costs associated with the management of patients with multiple chronic diseases (11).
In the United States care for people with chronic disease represents 70% of healthcare expenditure (12), but the associated loss of productivity due to disability, unscheduled sick leave, a decrease in effectiveness in the workplace, an increase in occupational accidents or negative impacts on work quality and customer care represent an even higher financial cost to countries than those related to healthcare services.
Figure 4. Distribution of Medicare Cover and Expenditure in Different Sectors of the Population
Source: Medicaid (13)
Dependence associated with chronic diseases
In 2006 the WHO estimated that there were 650 million people with disabilities worldwide, representing 10% of the population (14). In the US it has been shown that disabled people account for most of the Medicaid budget despite representing a minority of cases (Figure 4) (13).
Most polypathologies are associated with a high level of dependence, a concept which goes beyond disability in as much as it implies a person's need for support in order to perform ordinary everyday activities (as a result of physical, psychological, intellectual or sensory limitations). It has been estimated that people who are dependent as a result of chronic diseases represent about 2.5% of the total population (15).
A recent report by the Organization for Economic Co-operation and Development (OECD) highlights important levels of disparity among countries in terms of the amount of resources available to support dependent individuals, and a dearth of data on the economic scale of the services provided by family caregivers (16). The latter places a serious limitation on estimates of the costs associated with chronic diseases as it is widely recognized that most of the cost of caring for dependent people is assumed by family members (17). As the proportion of dependent people increases and fertility rates decrease, it is reasonable to expect a shift in this burden and its related costs from family members to the traditional system of health and social services (18, 19).
Influence of lifestyles and disease risk factors on healthcare costs
The prevalence of chronic diseases is closely related to unhealthy lifestyle habits (see Chapter 3). In the United States, the estimated cost represented by these habits in 2000 was (20):
- Smoking: 75.5 billion dollars in medical costs and 92 billion dollars associated with productivity losses (21).
- Obesity and excess weight (2002): 132 billion dollars (92 billion in direct costs and 40 billion in indirect costs) (22).
- Poor nutrition: 33 billion dollars derived from medical costs and 9 billion dollars of lost productivity as a result of cancer, cerebrovascular accidents and diabetes which can be attributed to bad nutrition (www.cdc.gov/nccdphp).
One study found that these risk factors increase expenditure by 25% (23). Altogether, smoking, alcoholism, obesity and hypertension consume 1.5% of GDP in China and 2.1% in India (24). The cost increases with the number of health risk factors (Figure 5).
Figure 5. Estimated 2008 US Healthcare Cost per person by extent of risk factors (figures in US dollars)
Source: PricewaterhouseCoopers 2008 - World Economic Forum - Working Towards Wellness Business Rationale (25)
Healthcare costs are higher in people who are sedentary without being overweight than in obese people who are physically active (26). In Spain, two out of three children of school age and 38% of young people appear to be sedentary in their free time (27).
Interventions over lifestyles could have a big impact on expenditure on chronic diseases, essentially through weight reduction, improved nutrition, regular exercise, giving up smoking and early diagnosis and treatment (Chapter 3). Unfortunately, most countries around the world, and even organizations such as the WHO, allocate insufficient resources to health promotion and disease prevention. The latter, for instance, invested less than 8% of its budget in activities related to these two areas, and to mental health, substance abuse and the management of chronic diseases (28). The early targeting of risk factors, whether through pharmacological or behavioral interventions, has many potentially positive effects (Table 1).
Table 1. Cost per Group of Countries per Quality-adjusted Life year of Cholesterol and Hypertension Level Control Measures.
Source: Murray et al. (2003) (29) Centers for Disease Control and Prevention. (2004) (30).
What do we need to know?
Most of the questions related to the economic, social and political implications of multiple chronic diseases remain unaddressed (31).
What are the total costs associated with the management of complex chronic diseases?
The estimates must include data on healthcare costs, costs associated with productivity loss and disability, and to family care-giving for different combinations of diseases.
- What are the economic implications of different strategies for the provision of coordinated services (health and social) to people living with multiple chronic diseases?
- What is the most appropriate model of resource allocation across health promotion, disease prevention, healthcare and social service activities to minimize the economic and social impact of multiple chronic diseases?
- What interventions could reduce the productivity loss associated with multiple chronic diseases?
- What technological innovations could offer real, cost-effective alternatives to current care models?
- What is the impact of multiple chronic diseases on the lives of caregivers?
- What policies could lead to a reduction in the prevalence and the economic consequences of multiple chronic diseases?
Social and political implications
- What is the impact of multiple chronic diseases on the lives of caregivers? What new roles, workflows and supportive services are needed to relieve their burden?
- What policies could lead to a large enough reduction in the prevalence and the economic consequences of multiple chronic diseases?
- Could key regions be transformed into living laboratories with the conditions necessary for the development, refinement, implementation and evaluation of innovative ways to optimize the management of polypathology?
- What strategies are needed to position the management of polypathology among the top priorities for leading political, academic, clinical, community and corporate organizations interested in the sustainability of the health system?
What strategies could fill the gaps?
Given the potentially devastating effects that multiple chronic diseases could have on the economy and on society at large, bold policies would need to be developed and implemented to facilitate the transformation of existing health and social services. Such policies should at the least make it easier to fill most of the gaps identified in all of the preceding chapters, with an emphasis on:
- Efficient monitoring of the incidence, prevalence and impact of multiple chronic diseases (Chapters 1 and 2).
- Bold health promotion and disease prevention efforts at all levels (Chapter 3).
- The implementation of innovative models for complex chronic disease management, fostering leadership at the front line and bottom-up innovation (Chapter 4).
- The adaptation of existing health and social services to promote optimal integration and coordination of roles, workflows and processes at all levels (Chapter 6).
- The minimization of unnecessary suffering and the optimization of supportive care services throughout the entire natural history of multiple chronic diseases, and particularly at the end of life, for patients and their caregivers (Chapter 7).
- Strategies to engage people living with multiple chronic diseases and their caregivers in effective self-management programs (Chapter 5), demedicalizing their care as much as possible (Chapter 8).
Achieving this will not be easy. In fact, it could be argued that the slow nature of the policy-making process and the resistance to change that pervades all levels of the health system will hinder our ability to introduce the radical changes that are required to ensure that people living with multiple chronic diseases can achieve optimal quality of life without bankrupting the economy.
The jury is out. Let us hope that we have the foresight and courage necessary to bring about the creative partnerships among the government, academic institutions, the public and industry; the rigorous trans-disciplinary research and development work; the effective knowledge mobilization and management; and the level of political will needed to meet the unprecedented challenges created when we live long enough to accumulate multiple chronic diseases.
Francisco Martos and Emilio Herrera wrote the first draft of this chapter in Spanish and approved its English translation. Alejandro Jadad revised the English translation extensively and approved it (with support from Francisco Martos) before its release for external contributions through the OPIMEC platform in both languages. Jaime Espín made important contributions, which Francisco Martos incorporated into a revised version of the chapter, which was approved by Emilio Herrera, and the other contributors. This version was further revised by Richard Smith. Alejandro Jadad made some additional modifications to the text and approved the final version that was included in the paper-based book.
Responsibility for the content rests with the contributors and does not necessarily represent the views of Junta de Andalucía or any other organization participating in this effort.
Narcis Gusi made insightful comments to the chapter that did not lead to changes to its contents.
How to reference
Martos F*, Herrera E*, Espín J, Jadad AR, Smith R. [*Main contributors] Socioeconomic
implications. In: Jadad AR, Cabrera A, Martos F, Smith R, Lyons RF. When people live with
multiple chronic diseases: a collaborative approach to an emerging global challenge. Granada:
Andalusian School of Public Health; 2010. Available at: http://www.opimec.org/equipos/when-people-live-with-multiple-chronic-diseases
Creative commons license
implications by Martos F and Herrera E is licensed under a Creative Commons Reconocimiento-No comercial-Sin obras derivadas 3.0 España License.
No comments yet. Add your comment in the form below.